Literature DB >> 17405866

Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction.

Scott G Summerfield1, Kevin Read, David J Begley, Tanja Obradovic, Ismael J Hidalgo, Sara Coggon, Ann V Lewis, Rod A Porter, Phil Jeffrey.   

Abstract

The dispositions of 50 marketed central nervous system (CNS) drugs into the brain have been examined in terms of their rat in situ (P) and in vitro apparent membrane permeability (P(app)) alongside lipophilicity and free fraction in rat brain tissue. The inter-relationship between these parameters highlights that both permeability and brain tissue binding influence the uptake of drugs into the CNS. Hydrophilic compounds characterized by low brain tissue binding display a strong correlation (R(2) = 0.82) between P and P(app), whereas the uptake of more lipophilic compounds seems to be influenced by both P(app) and brain free fraction. A nonlinear relationship is observed between logP(oct) and P over the 6 orders of magnitude range in lipophilicity studied. These findings corroborate recent reports in the literature that brain penetration is a function of both rate and extent of drug uptake into the CNS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405866     DOI: 10.1124/jpet.107.121525

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  76 in total

Review 1.  Improving the prediction of the brain disposition for orally administered drugs using BDDCS.

Authors:  Fabio Broccatelli; Caroline A Larregieu; Gabriele Cruciani; Tudor I Oprea; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2011-12-21       Impact factor: 15.470

Review 2.  Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain.

Authors:  Yi Zheng; Xijing Chen; Leslie Z Benet
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

3.  Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum.

Authors:  Erin Milner; Jason Sousa; Brandon Pybus; Victor Melendez; Sean Gardner; Kristina Grauer; Jay Moon; Dustin Carroll; Jennifer Auschwitz; Montip Gettayacamin; Patricia Lee; Susan Leed; William McCalmont; Suzanne Norval; Anchalee Tungtaeng; Qiang Zeng; Michael Kozar; Kevin D Read; Qigui Li; Geoffrey Dow
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-07-13       Impact factor: 2.441

Review 4.  Physiologically based pharmacokinetic modelling of drug penetration across the blood-brain barrier--towards a mechanistic IVIVE-based approach.

Authors:  Kathryn Ball; François Bouzom; Jean-Michel Scherrmann; Bernard Walther; Xavier Declèves
Journal:  AAPS J       Date:  2013-06-20       Impact factor: 4.009

Review 5.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

6.  Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor Therapy.

Authors:  Minjee Kim; Janice K Laramy; Gautham Gampa; Karen E Parrish; Richard Brundage; Jann N Sarkaria; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2019-10-16       Impact factor: 3.922

7.  Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic).

Authors:  Chad M Kormos; Pauline W Ondachi; Scott P Runyon; James B Thomas; S Wayne Mascarella; Ann M Decker; Hernán A Navarro; Timothy R Fennell; Rodney W Snyder; F Ivy Carroll
Journal:  J Med Chem       Date:  2018-08-29       Impact factor: 7.446

8.  Blood-brain barrier permeability and brain uptake mechanism of kainic acid and dihydrokainic acid.

Authors:  Mikko Gynther; Aleksanteri Petsalo; Steen H Hansen; Lennart Bunch; Darryl S Pickering
Journal:  Neurochem Res       Date:  2014-12-09       Impact factor: 3.996

9.  Real-time imaging and quantitative analysis of doxorubicin transport in a perfusable microvessel platform.

Authors:  Max I Bogorad; Peter C Searson
Journal:  Integr Biol (Camb)       Date:  2016-08-15       Impact factor: 2.192

10.  Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists.

Authors:  Md Toufiqur Rahman; Ann M Decker; Tiffany L Langston; Kelly M Mathews; Lucas Laudermilk; Rangan Maitra; Weiya Ma; Emmanuel Darcq; Brigitte L Kieffer; Chunyang Jin
Journal:  J Med Chem       Date:  2020-11-18       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.